Orgasm and Ejaculation Disorders
Abstract
Abstract Disorders of ejaculations are among the most complex complaints of patients seeking first medical help for sexual dysfunction. Among these, premature ejaculation (PE), delayed ejaculation (DE), retrograde ejaculation, and anorgasmia are the most frequently reported, and their impact on patients’ quality of life can be major. Although numerous preclinical and clinical studies have been published over the last two decades, the true pathophysiological mechanisms behind ejaculation remain unclear. In this context, this chapter aims at providing the latest evidence regarding ejaculation physiology together with detailed epidemiological data, diagnostic work-up, and treatment options upon PE, DE, retrograde ejaculation, and anorgasmia.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.